EDAP TMS SA to Announce First Quarter 2022 Financial Results on May 17, 2022
May 10, 2022 08:30 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on, Wednesday, May 18th at 8:30 am EDT LYON, France, May 10, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)
May 05, 2022 08:30 ET
|
EDAP TMS S.A.
AUA is the largest annual gathering of urologists worldwide LYON, France, May 5, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,...
Ovia Health Taps Digital Health Innovator Dr. Leslie Saltzman as Chief Medical Officer
April 13, 2022 09:00 ET
|
Ovia Health
BOSTON, April 13, 2022 (GLOBE NEWSWIRE) -- Ovia Health, the only clinically-backed digital family health platform, today announced Dr. Leslie Saltzman as the company’s new chief medical officer. In...
EDAP Provides Corporate Update on US Focal One® Installation Growth
April 12, 2022 08:00 ET
|
EDAP TMS S.A.
Company announces Focal One® placements at three renowned academic institutions in March LYON, France, April 12, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in...
EDAP Reports Fourth Quarter and Full Year 2021 Results
March 30, 2022 16:35 ET
|
EDAP TMS S.A.
Full year revenue of approximately EUR 44.1 million (USD 51.9 million) as compared to EUR 41.7 million (USD 47.8 million) for the full year 2020Full year US HIFU treatment volumes increased 65% over...
EDAP TMS SA to Announce Fourth Quarter 2021 Financial Results on Wednesday, March 30, 2022
March 21, 2022 08:00 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, March 31, at 8:30 am ET LYON, France, March 21, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today...
Sema4 Announces Nationwide Expansion of Disparity Study to Deliver Precision Oncology Care to Underserved Communities
March 16, 2022 08:00 ET
|
Sema4
- The REPRESENT Study Will Create One of the Most Diverse and Comprehensive Clinico-genomic Datasets to Uncover and Address Disparities in Cancer Care - Sema4’s Chief Medical Science Officer Will...
VeeOne Health Announces VeeGo 360 for Continuous and Intermittent Remote Patient Monitoring
March 09, 2022 08:00 ET
|
VeeOne Health
ROSEVILLE, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- VeeOne Health, a US-based provider of a complete telehealth platform and services for the full continuum of healthcare, today announced VeeGo...
VeeOne Health Begins Developing RPM Sensor Patch
February 16, 2022 09:00 ET
|
VeeOne Health
ROSEVILLE, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- VeeOne Health, a US-based provider of a complete telehealth platform and services for the full continuum of healthcare, today announced that it...
VeeOne Health Earns Full URAC Accreditation
February 08, 2022 10:00 ET
|
VeeOne Health
ROSEVILLE, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- VeeOne Health, a US-based provider of a complete telehealth platform and services for the full continuum of healthcare, today announced that the...